ESR1 and breast cancer: In order to better understand the biological characteristics of BBD, a few authors have focused on estrogen receptor (ER) 7, 8, progesterone receptor (PR) 9, and Ki67 7, 10, 11 as biomarkers expressed in benign lesions that are not in proximity to concomitant breast cancer.